Evidence map›Paper›PMID 34804715›Full record

ArticleCureus2021

Single Institution Experience of Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer: Comparison of Two Dose Regimes and a Perspective on Ideal Dose Regimens.

Mary R Nittala, William N Duggar, Eswar Mundra, Satya Packianathan, Maria L Smith, William C Woods, Jeremy Otts, Rahul Bhandari, Robert Allbright, Pierre E De Delva and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Mary R NittalaRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
William N DuggarRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
Eswar MundraRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
Satya PackianathanRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
Maria L SmithRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
William C WoodsRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
Jeremy OttsRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
Rahul BhandariRadiation Oncology, G.V. (Sonny) Montgomery VA Medical Center, Jackson, USA.
Robert AllbrightRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
Pierre E De DelvaSurgery, University of Mississippi Medical Center, Jackson, USA.
Jacob R MoremenSurgery, University of Mississippi Medical Center, Jackson, USA.
Claus Chunli YangRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
Srinivasan VijayakumarRadiation Oncology, University of Mississippi Medical Center, Jackson, USA.
G.V. (Sonny) Montgomery VA Medical Center · USUniversity of Mississippi Medical Center · USJackson Memorial Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Stereotactic body radiation therapy (SBRT) is an effective treatment for early-stage non-small cell lung cancer (NSCLC) patients who are either medically inoperable or who decline surgery. SBRT improves tumor control and overall survival (OS) in medically inoperable, early-stage, NSCLC patients. In this study, we investigated the effectiveness of two different SBRT doses commonly used and present our institutional experience. Purpose To determine the clinical outcomes between two treatment regiments (50 Gray [Gy]

Indexed as

adenocarcinomalung canceroverall survival (os)squamous cell carcinomastereotactic body radiation therapy

Identifiers

PMID34804715
PMCPMC8597860
OpenAlexW3205382406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.